<?xml version="1.0" encoding="UTF-8"?>
<p id="Par53">In the patent analyses, Brazilian assignees were the single representatives of LAC countries. It should be kept in mind that, given the common delays in the publication of patent filings in the country, the number of patents may be underestimated. Although Brazil’s performance was less expressive than the USA and China, it still had an important position, ahead of patent leaders like South Korea, Germany, and Japan. Its leading position among LAC countries is in accordance with the results obtained in the assessment of scientific publications. Brazil’s small share of ZIKAV patents (5%) seems to be consistent with the publication’s profile, which focused mostly on the clinical manifestations of ZIKAV and vector control, areas that do not necessarily involve technological development. It has been argued that vector control is necessary as an immediate measure for epidemic control, but it should be undertaken in combination with other efforts such as the implementation of an R&amp;D agenda and strengthening social programs and health systems [
 <xref ref-type="bibr" rid="CR35">35</xref>].
</p>
